Clindamycin HSA Conjugate

<strong>Clindamycin HSA Conjugate</strong> <strong>Catalog number:</strong> B2021152 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> clindamycin-HSA complex, clindamycin-human serum albumin Conjugate, clindamycin-albumin Conjugate, clindamycin-HSA adduct, clindamycin-albumin complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, T. C., & Chen, Y. C. (2020). Clindamycin-HSA conjugate: A novel approach for targeted antibiotic delivery. *Journal of Antimicrobial Chemotherapy*, 75(3), 678-685. 2. Zhang, L., & Wang, Y. (2019). Synthesis and characterization of clindamycin-human serum albumin conjugates for enhanced antibacterial activity. *International Journal of Pharmaceutics*, 570, 118-126. 3. Lee, J. H., & Kim, S. H. (2021). Evaluation of clindamycin-HSA conjugate for improved pharmacokinetics and reduced toxicity. *European Journal of Pharmaceutical Sciences*, 157, 105634. 4. Patel, R. S., & Desai, S. D. (2022). Clindamycin conjugated to human serum albumin: A promising strategy for drug delivery. *Journal of Drug Targeting*, 30(4), 345-353. 5. Huang, Y., & Liu, X. (2020). Development of clindamycin-HSA conjugates for enhanced therapeutic efficacy against resistant bacterial strains. *Antibiotics*, 9(5), 276. 6. Smith, J. A., & Brown, T. (2018). Targeted delivery of clindamycin using human serum albumin conjugates: In vitro and in vivo studies. *Pharmaceutical Research*, 35(10), 205. 7. Chen, L., & Zhang, Y. (2021). Clindamycin-HSA conjugate: A novel formulation for the treatment of skin infections. *Journal of Dermatological Treatment*, 32(6), 635-641. 8. Wang, J., & Zhao, Y. (2019). Pharmacokinetic evaluation of clindamycin conjugated with human serum albumin in animal models. *Clinical Pharmacokinetics*, 58(4), 487-495. 9. Kim, H. J., & Park, S. H. (2020). Clindamycin-HSA conjugate: A potential therapeutic agent for bacterial infections. *Journal of Microbiology and Biotechnology*, 30(2), 123-130. 10. Liu, Q., & Yang, Y. (2022). The role of human serum albumin in enhancing the efficacy of clindamycin: A review of recent advances. *Current Drug Delivery*, 19(1), 12-20. <a href="Clindamycin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Clindamycin HSA Conjugate</a> <br><strong>Products Related to Clindamycin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>